Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer
Open Access
- 1 October 2001
- journal article
- review article
- Published by BMJ in Molecular Pathology
- Vol. 54 (5) , 281-284
- https://doi.org/10.1136/mp.54.5.281
Abstract
Breast cancer is a common solid malignancy in women. Over the past decade, much progress has been made in understanding the biology of breast cancer. The use of molecular and immunohistochemical techniques is providing insights that will allow us to tailor the management of patients with breast cancer. In this review, progress in the understanding of lobular carcinoma in situ and atypical ductal hyperplasia, the use of the molecular marker CerbB2, and information gained from the morphological analysis of tumours arising in patients with BRCA1 and BRCA2 mutations is discussed. J Clin Pathol: Mol Pathol(J Clin Pathol: Mol Pathol 2001;54:281–284)Keywords
This publication has 60 references indexed in Scilit:
- Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breastEuropean Journal Of Cancer, 2000
- Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriersThe Lancet, 1998
- Consistency of histopathological reporting of breast lesions detected by screening: Findings of the U.K. National External Quality Assessment (EQA) schemeEuropean Journal Of Cancer, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinomaBreast Cancer Research and Treatment, 1991
- Enhanced detection of preinvasive breast cancer: Combined role of mammography and needle localization biopsyJournal of Surgical Oncology, 1989
- Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancerInternational Journal of Cancer, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985
- Lobular Carcinoma In Situ: A Rare Form of Mammary CancerPublished by Wiley ,1982